Loading...

International Healthcare And Digital Expansion Will Transform Emerging Markets

Published
09 Feb 25
Updated
01 Sep 25
AnalystConsensusTarget's Fair Value
HK$5.31
6.7% overvalued intrinsic discount
04 Sep
HK$5.66
Loading
1Y
41.9%
7D
-0.4%

Author's Valuation

HK$5.3

6.7% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 Sep 25
Fair value Increased 4.76%

Fosun International’s consensus price target has increased to HK$5.30, primarily reflecting stronger expected revenue growth and a considerable improvement in net profit margin. What's in the News Board meeting scheduled to review interim results and consider interim dividend payment for the six months ended 30 June 2025.

Shared on01 May 25
Fair value Increased 1.91%

Shared on23 Apr 25
Fair value Decreased 34%

AnalystConsensusTarget has decreased future PE multiple from 9.4x to 6.2x.

Shared on17 Apr 25
Fair value Decreased 0.53%

AnalystConsensusTarget has increased profit margin from 2.8% to 3.1% and decreased future PE multiple from 10.5x to 9.4x.

Shared on09 Apr 25
Fair value Increased 0.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.78%

AnalystConsensusTarget has increased revenue growth from 5.1% to 8.3%, increased profit margin from 2.3% to 3.0% and decreased future PE multiple from 13.8x to 9.7x.

Shared on26 Mar 25
Fair value Decreased 1.08%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 57%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 0.16%